RESUMEN
More and more women with cancer issues are now raising fertility concerns as survival improves and childbearing is delayed. Pregnancy is no longer contraindicated in cancer patients including breast and endometrial cancer survivors. In fact, survival in patients treated for breast cancer who subsequently become pregnant is actually higher than that in patients who do not become pregnant. "Therapeutic" abortions are no longer recommended. Assisted reproductive technology (ART) have been associated with ovarian neoplasms, but the association is probably not causal. Neither ART nor hormone replacement is contraindicated in cancer patients. Our institution is very supportive of patients and the difficult decisions cancer survivors face. Using a program of counseling and close collaboration between oncologists, perinatologists, and reproductive endocrinologists, informed patients are offered every possible option, including ART and uterine transplantation, to achieve their family planning objectives.
Asunto(s)
Cuello del Útero/cirugía , Neoplasias de los Genitales Femeninos/complicaciones , Infertilidad Femenina/terapia , Útero/trasplante , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/cirugía , Femenino , Neoplasias de los Genitales Femeninos/cirugía , Humanos , Infertilidad Femenina/etiología , Embarazo , Neoplasias del Cuello Uterino/complicaciones , Neoplasias del Cuello Uterino/cirugíaRESUMEN
OBJECTIVE: Our aim was to investigate the feasibility of MR imaging as a comprehensive preoperative imaging test for examination of liver donor candidates for adult-to-adult right lobe transplantation. SUBJECTS AND METHODS: Twenty-five consecutive donor candidates were examined at 1.5 T using a torso phased array coil with breath-hold T1- and T2-weighted imaging of the abdomen, MR cholangiography using T2-weighted turbo spin-echo imaging, and MR angiography and venography of the liver using two interpolated three-dimensional spoiled gradient-echo sequences (average dose of gadolinium contrast material, 0.17 mmol/kg). Images were interpreted for liver parenchymal and extrahepatic abnormalities; measurements of right and left lobe liver volumes; definition of hepatic arterial, portal venous, and hepatic venous anatomy; and definition of the biliary branching pattern. Findings were compared with those of conventional angiography in 13 patients, 11 of whom also had surgical findings for comparison. RESULTS: Nine patients were excluded as candidates for donation on the basis of MR imaging findings that included parenchymal or extrahepatic abnormalities in five patients, vascular anomalies in two, and biliary anomalies in three. Two patients who did not undergo surgery underwent conventional angiography that confirmed MR angiographic findings except for a small (<2 mm) accessory left hepatic artery missed on MR imaging. Of the nine patients who underwent successful right hepatectomy, all MR imaging findings were corroborated intraoperatively. In two patients, right hepatectomy was aborted at laparotomy because of intraoperative cholangiography findings; in one of them, the biliary finding was unsuspected on MR imaging. CONCLUSION: A comprehensive MR imaging examination has the potential to serve as the sole preoperative imaging modality for living adult-to-adult liver donor candidates provided improvements in definition of intrahepatic biliary anatomy can be achieved.
Asunto(s)
Hepatectomía , Trasplante de Hígado , Donadores Vivos , Imagen por Resonancia Magnética , Adulto , Angiografía , Conductos Biliares/anatomía & histología , Medios de Contraste , Estudios de Factibilidad , Femenino , Arteria Hepática/anatomía & histología , Venas Hepáticas/anatomía & histología , Humanos , Hígado/irrigación sanguínea , Angiografía por Resonancia Magnética , Masculino , Vena Porta/anatomía & histología , Estudios ProspectivosRESUMEN
PURPOSE: To determine the sensitivity and specificity of magnetic resonance (MR) imaging for detection of hepatocellular carcinoma (HCC) and dysplastic nodules (DNs) by using explantation correlation in patients with cirrhosis and no known HCC. MATERIALS AND METHODS: Seventy-one patients without a known history of HCC who underwent MR imaging and subsequent transplantation within 90 days were examined. Breath-hold turbo short inversion time inversion-recovery and/or T2-weighted turbo spin-echo MR images were obtained. Dynamic two- or three-dimensional gadolinium-enhanced gradient-echo MR images were obtained in the hepatic arterial, portal venous, and equilibrium phases. Prospective MR image interpretations were compared directly with explanted liver pathologic results. RESULTS: Eleven (15%) of 71 patients had hepatic malignancies; MR imaging enabled diagnosis of tumor in six (54%) of 11 patients. On a lesion-by-lesion basis, MR imaging depicted 11 of 20 hepatic neoplasms, for an overall sensitivity of 55%. MR imaging depicted four (80%) of five lesions larger than 2 cm, six (50%) of 12 lesions 1-2 cm, and one (33%) of three lesions smaller than 1 cm. MR imaging depicted only nine (15%) of 59 DNS: The specificities of MR imaging for detection of HCC and DNs on a per patient basis were 60 (86%) of 70 patients and 53 (85%) of 62 patients, respectively. CONCLUSION: MR imaging is insensitive for the diagnosis of small (<2-cm) HCCs and DNS:
Asunto(s)
Carcinoma Hepatocelular/diagnóstico , Cirrosis Hepática/complicaciones , Neoplasias Hepáticas/diagnóstico , Hígado/patología , Imagen por Resonancia Magnética , Adulto , Anciano , Carcinoma Hepatocelular/complicaciones , Reacciones Falso Positivas , Femenino , Humanos , Neoplasias Hepáticas/complicaciones , Masculino , Persona de Mediana Edad , Sensibilidad y EspecificidadRESUMEN
Recurrence of hepatitis C is a significant problem after liver transplantation. This prospective study was done to assess the rate of recurrence and discuss two possible treatment modalities that have been successful in avoiding retransplantation. Twenty-one patients underwent orthotopic liver transplantation for hepatitis C at a metropolitan medical center over a 34-month period. The mean follow-up interval was 13.4 +/- 2.2 months (range 5-28 months). The patients were routinely evaluated with clinic visits and liver function tests, specifically total bilirubin, serum glutamic-oxaloacetic transaminase, and gamma-glutamyl transpeptidase. If values were elevated, the patient was admitted to the hospital for liver biopsy. Ten of the 21 patients demonstrated recurrence on biopsy. Two of 10 patients required no therapy. Interferon A was initiated in the remaining eight. Three of the eight patients had no significant response to interferon and were given intravenous ribavirin under an experimental protocol. Two of these three showed significant improvement in liver function values. The third died of chronic rejection. The incidence of recurrent hepatitis C after liver transplantation is significant. Many centers have had to resort to retransplantation. Our results show that with early detection and aggressive treatment with interferon and ribavirin, hepatitis C can be controlled and retransplantation may be avoided.
Asunto(s)
Antivirales/uso terapéutico , Hepatitis C/terapia , Interferón-alfa/uso terapéutico , Trasplante de Hígado , Ribavirina/uso terapéutico , Adulto , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Prospectivos , RecurrenciaRESUMEN
The occurrence of a metastatic atrial myxoma after complete resection of the intracardiac lesion is rare. We treated a 66-year-old man who 13 years earlier had undergone resection of a left atrial myxoma, which had been diagnosed during a work-up of symptomatic cerebellar infarcts. He initially had a painless nonpulsatile mass near the radial artery. Surgery was performed to confirm the presumptive diagnosis of calcified ganglion, and subsequently he was found to have a pseudoaneurysm. The pathologic examination identified the tissue as myxoma. The results of echocardiography and cardiac magnetic resonance imaging failed to reveal any residual or new intracardiac tumor. The patient subsequently experienced swelling of the right leg and was found to have a 6 x 10 cm mass in the medial portion of his proximal thigh. At exploration this mass was found to extend from the profunda femoris artery, and it also compressed the femoral vein. Pathologic evaluation based on histologic and electron microscopic features of this lesion confirmed this lesion to be myxoma. Review of the literature reveals that metastatic atrial myxoma is a rare lesion, and such a delayed occurrence after resection of the cardiac lesion has been infrequently reported. This suggests that patients with atrial myxoma may be at risk for the appearance of intravascular metastatic tumor long after resection of their original intracardiac tumor.
Asunto(s)
Neoplasias Cardíacas/cirugía , Mixoma/cirugía , Anciano , Arterias/patología , Arterias/cirugía , Atrios Cardíacos , Neoplasias Cardíacas/patología , Neoplasias Cardíacas/secundario , Neoplasias Cardíacas/ultraestructura , Humanos , Masculino , Mixoma/patología , Mixoma/ultraestructura , Metástasis de la Neoplasia , MuñecaAsunto(s)
Enfermedad Injerto contra Huésped/etiología , Intestino Delgado/trasplante , Animales , Enfermedad Injerto contra Huésped/inmunología , Enfermedad Injerto contra Huésped/patología , Ganglios Linfáticos/inmunología , Ganglios Linfáticos/patología , Masculino , Tamaño de los Órganos , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/mortalidad , Complicaciones Posoperatorias/patología , Ratas , Ratas Endogámicas BN , Ratas Endogámicas Lew , Bazo/patología , Trasplante Homólogo/mortalidadRESUMEN
Small bowel and its mesentery contain considerable amounts of lymphoid tissue that can mediate graft-versus-host disease in small bowel transplant (SBT) recipients. Present studies determined the existence of GVHD in a fully allogeneic SBT model and examined the effect of donor pretreatment with ALS in eliminating GVHD. Adult male Lewis (Lew) rats received orthotopic small bowel transplants from untreated (LewxBN)F1 (LBNF1) donors (group 1) or Brown Norway (BN) donors that were untreated (group 2) or pretreated with ALS (days -2 and -1) (group 3). All recipients were treated with cyclosporine 15 mg/kg/day i.m. on days 0-6 postoperatively. Animals were weighed and examined daily for signs of rejection and GVHD. No animals in groups 1 or 3 showed any physical signs of GVHD, but all of those in group 2 had characteristic weight loss, diarrhea, and dermatitis between 4 and 6 weeks postoperatively, from which they all recovered. Histologic examination of skin and spleen at this time confirmed the presence of GVHD. The relative spleen weight [( spleen weight/body weight] x 100) of group 2 animals was also significantly greater than that of unoperated control Lew animals. Spleen cells obtained from group 2 animals at the time of subclinical GVHD, but not cells from group 1 or 3 animals, caused enlargement of popliteal lymph nodes when they were injected into the footpads of Lew rats. This study shows that GVHD can manifest itself in recipients of a fully allogeneic small bowel transplant even when rejection is prevented by effective immunosuppression with CsA. However, combined use of recipient treatment with CsA and pretreatment of donor animals with ALS eliminates all manifestations of GVHD.
Asunto(s)
Enfermedad Injerto contra Huésped/inmunología , Intestino Delgado/trasplante , Animales , Enfermedad Injerto contra Huésped/patología , Ganglios Linfáticos/patología , Tamaño de los Órganos , Ratas , Ratas Endogámicas , Piel/patología , Bazo/patologíaRESUMEN
We compared the immunologic and metabolic effects of systemic (i.e., caval) versus portal venous drainage of small-intestinal allografts in rats. Survival times in either unidirectional rejection or graft-versus-host disease models were not significantly altered by the route of venous drainage. Portoportal and portacaval isografts and controls were then pair-fed after transplantation. After 6 weeks of pair-feeding, weight gain, plasma amino acid concentration, and the histologic appearance of the liver were similar among the three groups. Hepatic protein synthesis was greater in pair-fed rats with portoportal isografts, although this difference disappeared in the fasted state. Our data suggest that there is little immunologic or metabolic advantage of portal versus systemic venous drainage of small-intestinal allografts in rats. Because the latter is technically simpler, it may be preferable in small-bowel transplantation.